Search Results
Results found for "richard leduc"
- When January Looks Different by March: Orthosteric vs. Allosteric Insights from Our Latest AMA
Strategic Use of Repurposing and Data Controls Drug repurposing offers reduced uncertainty and extensive Robust controls distinguish mechanism from artifact Multipathway analysis reduces false confidence Neglecting
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
drugs that enhance or inhibit receptor activity without directly competing with ligands, potentially reducing For instance, a patient with a specific variant of the β2AR gene that reduces potency might require a
- Protein Uncoupling as an Innovative Practice in Diabetes Mellitus Treatment: A Metabolic Disorder
UCPs are hypothesised to be triggered by superoxide and then reduce mitochondrial free radical production
- Signals in Motion: Pain, Metabolism & Terry’s Corner
Blocking this chemokine axis reduces pain hypersensitivity by dampening neuroinflammation and glial
- Why Fundraising Mistakes Kill Strong Biotech Startups
Experiments are prioritized because they fit a clean story, not because they meaningfully reduce scientific Decisions that reduce tension are prioritized over decisions that resolve it. 👉 The company does not This reduces internal ambiguity and prevents fundraising pressure from reopening questions that were
- Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late
GPCR the best for the sake of promoting more educational opportunities that are sorely needed in the
- X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE
weeks after X4 pulled together a $55 million PIPE and amended a loan facility with Hercules Capital to reduce
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Deviations—like reduced maximal responses or non-linear regressions—signal confounding kinetics, receptor Inverse Agonists and Hemi-Equilibria In systems with constitutive receptor activity , inverse agonists reduce
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Studying these routes may reduce side-effects when using GPCR-based therapies. Reduced background noise: Improvements in signal-to-noise ratio are key in CNS assays.
- 📰 GPCR Weekly News, March 4 to 10, 2024
Their research reveals how VU0486846 reduces neurogliosis in female Alzheimer's mice. Dr. Neuroscience A M1 muscarinic acetylcholine receptor-specific positive allosteric modulator VU0486846 reduces
- Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
This compound has vastly reduced brain penetration and is devoid of significant off-target liability.
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
By reducing receptor density, researchers can transform full agonists into partial ones—allowing comparative Model patient-like pathophysiological states (e.g., reduced receptor expression in heart failure).
- Crinetics Presents Clinical And Research Results At ENDO 2022
Crinetics recently reported that administration of CRN04894 reduced both serum cortisol levels and 24
- SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
that SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher Education
- Structure of Mycobacterium tuberculosis Cya, an evolutionary ancestor of the mammalian membrane...
Neutralization of the negatively charged extracellular pocket Ex1 destabilizes the cytosolic helical domain and reduces
- Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..
In a LPS-induced lung inflammation model in mice, ACT-660602 led to significantly reduced recruitment
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
These effects include reducing the atherosclerotic plaque area, improving the serum lipid profile, attenuation
- Endogenous ligand recognition and structural transition of a human PTH receptor
physiological properties: PTH evokes prolonged Gs activation, whereas PTHrP evokes transient Gs activation with reduced
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
These effects include reducing the atherosclerotic plaque area, improving the serum lipid profile, attenuation
- Endogenous ligand recognition and structural transition of a human PTH receptor
physiological properties: PTH evokes prolonged Gs activation, whereas PTHrP evokes transient Gs activation with reduced
- Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin...
Def and Mrgpra2 mutant animals both exhibited skin dysbiosis, with reduced microbial diversity and expansion
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
Registration deadline: October 25, 2024 🔥 Why You Should Enroll Now: Cost-effective & Distinctive Educational Our goal is to ensure that education is within reach for everyone!
- Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial ...
Administration of Exendin-4 to MI rats reduced the infarct size and reversed the aforementioned signaling increased mRNA levels of MnSOD, protein levels of β-arrestin-2 and PP2A, and β-catenin phosphorylation but reduced β-arrestin-2 can stimulate PP2A to dephosphorylation Smad3 (inhibition) and GSK3β (activation), thus reduces
- Dr. JoAnn Trejo - Dr. GPCR Podcast
Sharing how she became a scientist, educator, mentor, and the powerhouse we know today.
- Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
, small chemicals, hormones, cytokines, and, recently, gene editing techniques, have been tested to reduce
- The Real Cost of Strategic Overload in Biotech
Each program appears to increase optionality and reduce risk. 👉 This is where strategic overload begins In the short term, this approach appears to reduce risk and strengthen the story ahead of biotech fundraising
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
. 📌 Reasons to Consider Enrolling Now: Exceptional Educational Opportunities at Unbeatable Value Our We aim to make education accessible to all!
- GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation
CLH536, a novel GPR84 antagonist discovered by us, suppresses colitis by reducing the polarization and
- Accelerating GPCR Drug Discovery
tracking to data workflows, I design simple, scalable tools that surface insights early and dramatically reduce
- The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of ...
intranasal infection with MCMV M33ΔC38, the absence of M33 CREB Gq/11-dependent signalling correlated with reduced mobilisation of lytically-infected DC to draining lymph node high endothelial venules (HEVs) and reduced














